What You Should Know:
- Get a Second Opinion Inc. has officially emerged from stealth mode, unveiling its AI-powered platform designed to transform how patients understand and manage their medications.
- By analyzing a vast body of FDA data, clinical studies, and real-world outcomes, the company offers personalized insights that help patients make more informed decisions about prescription and over-the-counter (OTC) treatments.
Get a Second Opinion Launches AI-Driven Medication
Read More
Digital Health | News, Analysis, Insights - HIT Consultant
Ciba Health and ADA Join Forces to Transform Chronic Care
What You Should Know:
- Ciba Health, a digital health platform focused on personalized, outcomes-based care for chronic conditions, has announced a collaboration with the American Diabetes Association (ADA) to enhance prevention and treatment strategies for type 2 diabetes.
- This partnership brings together Ciba Health’s root-cause approach with the ADA’s national leadership in advocacy, research, and public education.
Ciba Health and American Diabetes Association Collaborate to
Read More
Philips & March of Dimes to Integrate Maternal Health Content into Avent Pregnancy+ App
What You Should Know:
- Philips and March of Dimes, the nation’s leading nonprofit fighting for the health of all moms and babies, announced a new collaboration aimed at improving maternal health education.
- The partnership will see essential March of Dimes content integrated into the widely used Philips Avent Pregnancy+ app, with the goal of enhancing health literacy and raising awareness on critical topics such as preparing for a Neonatal Intensive Care Unit (NICU) stay,
Read More
Abridge Launches AI-Powered Pediatric Well Visit Note Type
What You Should Know:
- Abridge, a company specializing in AI-powered clinical documentation, announced the launch of a new pediatric well visit note type within its platform.
- The enhancement leverages Abridge's advanced Contextual Reasoning Engine to automatically generate clinically useful and billable documentation tailored to the unique, structured needs of pediatric well visits, which vary significantly by a child's age and developmental stage.
- The new feature was
Read More
Helix Launches New PGx Tests for Chemotherapy (DPYD) & Alzheimer’s Drug (APOE) Safety
What You Should Know:
- Helix, a leader in precision health announced the release of a new suite of pharmacogenomics (PGx) tests designed to enhance personalized care, particularly in oncology and neurology.
- Key among these are a test to identify patients with DPYD gene variants who may be at increased risk for severe side effects from certain chemotherapies, and a first-of-its-kind test that assesses APOE status relevant to newly available Alzheimer's drugs.
Tailoring
Read More
Drug Diversion in Hospitals Persists as an Underreported “Elephant in the Room”
What You Should Know:
- Despite increased investments in detection programs, drug diversion—the illegal obtaining of prescription drugs by healthcare staff—continues to be a significant and often underreported issue within U.S. hospitals and health systems, according to the fifth edition of the "State of Drug Diversion" report released by Wolters Kluwer Health.
- The comprehensive survey of nurse leaders, pharmacists, risk managers, and drug diversion program leaders reveals that
Read More
German Bionic Unveils First True Augmented AI Exoskeleton, Exia
What You Should Know:
- German Bionic, the robotics pioneer renowned for first connecting exoskeletons to the cloud, launches Exia – its most advanced wearable device to date and the world’s first exoskeleton powered end-to-end by true Augmented AI.
- Informed by insights from billions of real-world motion data points collected across industries including manufacturing, logistics, retail, and healthcare, Exia aims to set a new benchmark for strength, intelligence, and
Read More
Brooklyn Health Secures $6.5M to Expand AI-Powered Precision for Clinical Trial Endpoints
What You Should Know:
- Brooklyn Health, a neuroscience technology company focused on objective measurement of mental health announced it has secured $6.5M in seed funding led by HealthX, with participation from Metrodora Ventures, Story Ventures, RiverPark Ventures, Laconia Capital, Everywhere Ventures, Hypothesis Studio, Blue Falcon Capital, and others.
- The funding coincides with the company's debut of its new electronic clinical outcome assessment (eCOA) solution, Willis. Willis
Read More
John Snow Labs Acquires WiseCube to Bolster AI-Powered Biomedical Knowledge and Drug Discovery
What You Should Know:
- John Snow Labs, the AI for healthcare company announced its acquisition of WiseCube, a pioneer in biomedical knowledge graphs and AI-powered literature analysis. Financial details of the acquisition were not disclosed.
- The strategic move is set to significantly enhance John Snow Labs' mission to deliver responsible, accurate, and explainable healthcare AI solutions by integrating WiseCube’s billion-scale knowledge platform.
Enhancing AI Capabilities in
Read More
Smith+Nephew Awarded $75M DoD Contract to Supply Advanced Wound Therapy Systems
What You Should Know:
- Global medical technology company Smith+Nephew has been selected to provide its RENASYS◊ TOUCH Negative Pressure Wound Therapy (NPWT) Systems to the U.S. Department of Defense (DoD).
- The single-award contract, facilitated through the Defense Logistics Agency (DLA), spans 10 years and is valued at up to $75M.
- The agreement will equip military medical providers with an advanced solution for managing complex wounds across various stages of care, from
Read More
